Skip to content

Author

Shamsun Nahar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

SGLT2 inhibitors in chronic kidney disease: cardiorenal outcomes, safety, and implementation in primary care

SGLT2 inhibitors are foundational therapies for CKD, providing consistent renal and cardiovascular benefits with an acceptable safety profile in patients with and without diabetes, however, substantial gaps remain in their implementation in primary care.

Shamsun Nahar, S. Haque, Sananda Halder · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.